PPA
ZYNE

Parametric Portfolio Associates’s Zynerba Pharmaceuticals, Inc ZYNE Stock Holding History

Parametric Portfolio Associates’s Portfolio ZYNE Stock Details ZYNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-13,971
Closed -$54K – 4030
2020
Q1 		$54K Buy
+13,971
New +$64.9K ﹤0.01% 3829
2018
Q4 		– Sell
-10,549
Closed -$86K – 3977
2018
Q3 		$86K Sell
10,549
-12,296
-54% -$94.4K ﹤0.01% 3866
2018
Q2 		$223K Buy
22,845
+4,258
+23% +$43.6K ﹤0.01% 3667
2018
Q1 		$162K Buy
18,587
+185
+1% +$2K ﹤0.01% 3802
2017
Q4 		$230K Buy
+18,402
New +$211K ﹤0.01% 3701
2017
Q3 		– Sell
-13,121
Closed -$223K – 4059
2017
Q2 		$223K Buy
+13,121
New +$261K ﹤0.01% 3766

Other funds holding ZYNE

EMG
ETF Managers Group Summit, New Jersey $3.1B AUM 17.12% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
ZCA
Zeke Capital Advisors Berwyn, Pennsylvania $1.53B AUM 17.37% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PCM
Prentice Capital Management Greenwich, Connecticut $52.9M AUM 2.04% 1-Year Est. Return
AI
AdvisorShares Investments Bethesda, Maryland $828M AUM 37.72% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 57.61% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Parametric Portfolio Associates's ZYNE Position: Q2 2020 in Review

Parametric Portfolio Associates sold out of Zynerba Pharmaceuticals, Inc (ZYNE) in Q2 2020, closing a stake of 13,971 shares — an estimated $54K sold.

Parametric Portfolio Associates first reported a position in ZYNE in Q2 2017 and held it in 6 quarters. The position peaked at $230K in Q4 2017. 74 funds tracked by Wall St. Rank hold ZYNE as of Q2 2020.

  • Parametric Portfolio Associates reported no remaining Zynerba Pharmaceuticals, Inc position as of Q2 2020 after selling out during the quarter.
  • Parametric Portfolio Associates sold 13,971 Zynerba Pharmaceuticals, Inc shares in Q2 2020, an estimated $54K.
  • Parametric Portfolio Associates first reported a position in Zynerba Pharmaceuticals, Inc in Q2 2017 and held it in 6 quarters.
  • Parametric Portfolio Associates's Zynerba Pharmaceuticals, Inc position peaked at $230K in Q4 2017.
  • 74 funds tracked by Wall St. Rank held Zynerba Pharmaceuticals, Inc as of Q2 2020.

Based on Parametric Portfolio Associates's 13F filing for Q2 2020, filed 13 Aug 2020.